11.630.43% ( +0.05 )
Delay Midday Break: Nov 10, 11:30:00Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Jincheng Pharma(300233) the Revenue is 582.25 M (+1.83%);the EBIT is 38.95 M (+177.8%);the EPS is 0.0145 (+148.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.58B1.83%
----
----
EBIT
0.04B177.77%
----
----
EPS
0.0145148.57%
----
----
Upcoming earnings report - Annual FY2026
Available dateMar 26, 2027
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
